Status: current, Defined. Date: 30-Apr 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1878831000168115 | Montelukast (APL) (montelukast 5 mg) chewable tablet, 30 tablets, bottle (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1878841000168112 | Montelukast (APL) 5 mg chewable tablet, 30, bottle | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Montelukast (APL) 5 mg chewable tablet, 30, bottle | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Montelukast (APL) 5 mg chewable tablet, 30, bottle | Is a | Montelukast (APL) 5 mg chewable tablet, 30 | true | Inferred relationship | Some | ||
| Montelukast (APL) 5 mg chewable tablet, 30, bottle | has TPUU | Montelukast (APL) 5 mg chewable tablet | true | Inferred relationship | Some | 1 | |
| Montelukast (APL) 5 mg chewable tablet, 30, bottle | has container type | bottle | true | Inferred relationship | Some | ||
| Montelukast (APL) 5 mg chewable tablet, 30, bottle | has TP | Montelukast (APL) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR